IsoRay (ISR) Reports Prelim. Q4 Revenue of $1.37M

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to IsoRay (ISR) Reports Prelim. Q4 Revenue of $1.37M

IsoRay Announces Preliminary Fourth Quarter F2017 Revenue of $1.37 Million, 22% Year-over-Year Increase

August 4, 2017 8:00 AM EDT

RICHLAND, Wash., Aug. 4, 2017 /PRNewswire/ -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological cancers, today announced preliminary unaudited revenue and gross profit results for the fourth quarter and fiscal year ended June 30, 2017.

Preliminary unaudited revenue and gross profit for the fourth quarter of fiscal 2017:

Preliminary revenue for the three months ended June 30, 2017 was $1.37 million... More